NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DEBRA Research gGmbH

DEBRA Research gGmbH

Overview

DEBRA Research gGmbH is a non-profit, philanthropic drug development organization that operates as the research arm of DEBRA Austria, focusing on advancing treatments and cures for Epidermolysis Bullosa (EB) through research funding and strategic investments.

Year Founded

2021

Portfolio Companies

5

Investments

DEBRA Research gGmbH investments
CompanyDateStageLead
Healome TherapeuticsJul 2026SeedCo-investor
Mariposa TherapeuticsMar 2026SeedCo-investor
Eliksa TherapeuticsOct 2025StrategicLead
Dermaliq Therapeutics, Inc.May 2025StrategicCo-investor
Nova AnchoraApr 2025SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMunich
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.